Home
Conditions
Opioid-Induced Constipation

Clinical trial condition

Opioid-Induced Constipation

Explore clinical trials studying Opioid-Induced Constipation. Study availability and eligibility vary by location and protocol.

65 public trials 4 recruiting studies

Refine in advanced search Browse all conditions

Opioid-Induced Constipation trial results

Completed

TD-1211 IV/Oral Mass Balance Study

NCT01702194

Conditions: Chemically-Induced Disorders, Constipation, Mental Disorders, +7 more
Locations: Covance Madison, Wisconsin, United States

View Trial Details

Completed

Effect of Naloxegol on Postoperative Ileus in Patients Undergoing Cardiac Surgery

NCT04433390

Conditions: Chemically-Induced Disorders, Constipation, Mental Disorders, +7 more
Locations: CMC Ambroise Paré Neuilly-sur-Seine, Neuilly Sur Seine, France

View Trial Details

Completed

Electroacupuncture for Opioid-Induced Constipation in Cancer Patients: A Randomized Clinical Trial

NCT06537440

Conditions: Cancer, Chemically-Induced Disorders, Constipation, +9 more
Locations: First Teaching Hospital of Tianjin University of Traditional Chinese Medicine Tianjin, Tianjin Municipality, China

View Trial Details

Completed

Fiber-Enriched Enteral Nutrition and Opioid-Induced Constipation in the ICU

NCT07201428

Conditions: Chemically-Induced Disorders, Constipation, Constipation, Opioid-Induced, +7 more
Locations: Sisli Hamidiye Etfal Training Hospital Istanbul, Turkey (Türkiye)

View Trial Details

Completed

Safety and Preliminary Efficacy of BGP345A in Constipation Due to Opioid-based Medications

NCT05133076

Conditions: Chemically-Induced Disorders, Constipation, Mental Disorders, +7 more
Locations: Groupe hospitalier Saint-Joseph Paris, France

CHU d'Amiens Amiens, France

CHU DE NANTES (Hôpital Nord Laennec) Saint-Herblain, France

CH de Valenciennes Valenciennes, France

View Trial Details

Completed

European Study of Opioid Induced Constipation

NCT05149833

Conditions: Chemically-Induced Disorders, Constipation, Mental Disorders, +7 more
Locations: Norah Fagan Dublin, Ireland

View Trial Details

Completed

Naloxegol Drug Utilization Post Authorisation Safety Study

NCT02813148

Conditions: Chemically-Induced Disorders, Constipation, Mental Disorders, +7 more
Locations: Research Site Frankfurt am Main, Germany

Research Site Oslo, Norway

Research Site Mölndal, Sweden

Research Site London, United Kingdom

View Trial Details

Completed

Phase I Pharmacokinetics and Safety Study of Naloxegol in Paediatric OIC Patients

NCT02099591

Conditions: Chemically-Induced Disorders, Constipation, Constipation, Signs and Symptoms, Digestive, +7 more
Locations: Odense University Hospital Odense, Denmark

Rambam Medical Center, Oncology Institute Haifa, Israel

Schneider Children Medical Center Petah Tikva, Israel

Haukeland Universitetssykehus Bergen, Norway

View all 16 locations

View Trial Details

Completed

Real World Observational Study of Naloxegol for Patients With Cancer Pain Diagnosed With OIC.

NCT03638440

Conditions: Chemically-Induced Disorders, Constipation, Mental Disorders, +7 more
Locations: Aalborg University Hospital Aalborg, Denmark

Tampere University Hospital Tampere, Finland

Paul Papin à Angers et site René Gauducheau Nantes, France

Lubecker Onkologische Lübeck, Germany

View Trial Details

Completed

The Influence of Tramadol on Opioid-induced Bowel Dysfunction

NCT06385561

Conditions: Chemically-Induced Disorders, Constipation, Mental Disorders, +7 more
Locations: Aalborg University Hospital Aalborg, Denmark

View Trial Details

Opioid-Induced Constipation

Opioid-Induced Constipation trial results

Related conditions